Kennedy R. Lees
University of Glasgow
467 Papers
3.9K Citations
Kennedy R. Lees is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 86, co-authored 455 publications. Previous affiliations of Kennedy R. Lees include Ludwig Maximilian University of Munich & Cedars-Sinai Medical Center.
Chat about Author
Papers
Time spent at home poststroke: "home-time" a meaningful and robust outcome measure for stroke trials.
TL;DR: Home-time offers a robust, useful, and easily validated outcome measure for stroke, particularly across better recovery levels, and holds across all modified Rankin scale grades except 4 to 5.
Prehospital stroke care New prospects for treatment and clinical research
TL;DR: It is hypothesize that these new approaches in prehospital stroke care will not only shorten time to treatment and improve outcome but will also facilitate hyperacute stroke research by increasing the number of study participants within an ultra-early time window.
Study design of the international stroke trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study
Graeme J. Hankey,P Indekeu,G Waberzinek,C Majvald,Z Ambler,M Crowe,R Fogelholm,T Jolma,L Provinciali,S Pelonara,M G Ceravolo,P Anzola,M Mangoni,M Guidotti,R Migliacci,M Mollaioli,M Aimi,G Conti,C Corbacelli,C Gandolfo,M Conti,R Croce,M DelSette,C Finocchi,R Sterzi,A Brucato,M DeJiuli,M Rinaldi,G Bottini,G Ferraro,R Cavestri,M Arreghi,D Gori,E Longhini,R Agosti,G Malferrari,M Bondi,L Melini,W Garuti,F Sani,M Franciosini,M Bracaccia,C Gammarota,C Calandri,E Ciorba,G Micieli,Stefano Ricci,G Celani,Enrico Righetti,P Floridi,G Benemio,T Comparato,S Biagini,E Vignai,M Guerrieri,A Pirisi,F Pezzella,N Miele,S Grasselli,B Biscottini,G Alunni,A Boccali,M Cruciani,M Pacini,R Ibba,R Luccioli,F C Grandi,L Antoniutti,B Boniccioli,M Gregori,R Valli,N Guerrini,L Munari,A Perretti,A Mauro,Manuel Correia,C BurnsCox,Peter Sandercock,C Warlow,Martin Dennis,R Lindley,M Proctor,M Mathieson,F Waddell,Kennedy R. Lees,E Colquohoun,J Bamford,D Farquhar,R Tallis,I Scougal,R Meara,Graham Venables,C Holland,H Parry,K Kafetz,Ralph L. Sacco,D. E. Kargman,Sandercock Pag.,B Smith,Richard I. Lindley,C P Warlow,J Slattery,Joanna M. Wardlaw,R Sellar,H Fraser,L MacLean,L Robertson,S Honeyman,J MacKenzie,V Scoltock,A Brownlie,G Moody,H Taylor,S Anderson,D Charlton,M Cunniffe,I McCrindle,C McDonald,M Livingstone,Rory Collins,Richard Peto,P Dove,S Richards,L Wilhelmsen,J vanGijn,M Harrison +125 more
TL;DR: Recruitment rates in the pilot study indicated that if about 200 hospitals participated, recruitment could be completed by 1997 and reliable evidence on the balance of risk and benefit of early antithrombotic therapy might require a study with more than 20,000 patients.
Early clinical experience with the novel proteasome inhibitor PS–519
TL;DR: This study has demonstrated that proteasome inhibition is well tolerated by healthy subjects at levels that are maximally neuroprotective in experimental conditions and further clinical evaluation appears justified.
Anticoagulation After Stroke in Patients With Atrial Fibrillation
Riccardo Altavilla,Valeria Caso,Fabio Bandini,Giancarlo Agnelli,Georgios Tsivgoulis,Georgios Tsivgoulis,Shadi Yaghi,Karen L. Furie,Prasanna Tadi,Cecilia Becattini,Marialuisa Zedde,Azmil H. Abdul-Rahim,Kennedy R. Lees,Andrea Alberti,Michele Venti,Monica Acciarresi,Cataldo D'Amore,Maria Giulia Mosconi,Ludovica Anna Cimini,Jessica Fusaro,Paolo Bovi,Monica Carletti,Alberto Rigatelli,Manuel Cappellari,Jukka Putaala,Liisa Tomppo,Turgut Tatlisumak,Turgut Tatlisumak,Turgut Tatlisumak,Simona Marcheselli,Alessandro Pezzini,Loris Poli,Alessandro Padovani,Luca Masotti,Vieri Vannucchi,Sung Il Sohn,Gianni Lorenzini,Rossana Tassi,Francesca Guideri,Maurizio Acampa,Giuseppe Martini,George Ntaios,George Athanasakis,Konstantinos Makaritsis,Efstathia Karagkiozi,Konstantinos Vadikolias,Chrysoula Liantinioti,Maria Chondrogianni,Nicola Mumoli,Domenico Consoli,Franco Galati,Simona Sacco,Antonio Carolei,Cindy Tiseo,Francesco Corea,Walter Ageno,Marta Bellesini,Giorgio Silvestrelli,Alfonso Ciccone,Alessia Lanari,Umberto Scoditti,Licia Denti,Michelangelo Mancuso,Miriam Maccarrone,Leonardo Ulivi,Giovanni Orlandi,Nicola Giannini,Gino Gialdini,Tiziana Tassinari,Maria Luisa De Lodovici,Giorgio Bono,Christina Rueckert,Antonio Baldi,Sebastiano D'Anna,Danilo Toni,Federica Letteri,Martina Giuntini,Enrico Maria Lotti,Yuriy Flomin,Alessio Pieroni,Odysseas Kargiotis,Theodore Karapanayiotides,Serena Monaco,Mario Maimone Baronello,László Csiba,Lilla Szabó,Alberto Chiti,Elisa Giorli,Massimo Del Sette,Davide Imberti,Dorjan Zabzuni,Boris Doronin,Vera Volodina,Patrik Michel,Peter Vanacker,Kristian Barlinn,Lars-Peder Pallesen,Jessica Barlinn,Dirk Deleu,Gayane Melikyan,Faisal Ibrahim,Naveed Akhtar,Vanessa Gourbali,Maurizio Paciaroni +103 more
TL;DR: In this article, the authors reported that combining therapy with low-molecular-weight heparin leads to a worse outcome for acute cardio-embolic stroke patients because of a higher incidence of intracerebral intracortical stroke.